Found: 7
Select item for more details and to access through your institution.
Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00313-8
- By:
- Publication type:
- Article
A genetically stable Zika virus vaccine candidate protects mice against virus infection and vertical transmission.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00288-6
- By:
- Publication type:
- Article
An attenuated Zika virus NS4B protein mutant is a potent inducer of antiviral immune responses.
- Published in:
- NPJ Vaccines, 2019, v. 4, n. 1, p. N.PAG, doi. 10.1038/s41541-019-0143-3
- By:
- Publication type:
- Article
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. N.PAG, doi. 10.1038/s41467-020-19055-7
- By:
- Publication type:
- Article
A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation.
- Published in:
- Nature Communications, 2020, v. 11, n. 1, p. 1, doi. 10.1038/s41467-020-17892-0
- By:
- Publication type:
- Article